They also make the stomach move in slow motion, signal to the brain that you're feeling fuller earlier, and can make richer foods feel heavier than they used to
Innovation is high, competition is rising and the stakes are growing
February 24, 2026: UK Doctors May Receive Financial Incentive from Government for Prescribing Mounjaro, Other GLP-1s The UKs National Health Service has announced that it may award quality points to doctors who prescribe Mounjaro and other GLP-1s to qualifying patients for weight loss
The rising incidence of T2DM globally has further boosted the adoption of GLP-1 receptor agonists, especially as healthcare providers increasingly recommend these drugs due to their unique therapeutic benefits
Many plans are more likely to cover GLP-1 medications when prescribed for FDA approved indications such as Type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea
Zhou, B